KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) EPS (Basic): 2009-2024

Historic EPS (Basic) for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $7.78.

  • Quest Diagnostics' EPS (Basic) rose 8.46% to $2.18 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.64, marking a year-over-year increase of 14.89%. This contributed to the annual value of $7.78 for FY2024, which is 2.50% up from last year.
  • Per Quest Diagnostics' latest filing, its EPS (Basic) stood at $7.78 for FY2024, which was up 2.50% from $7.59 recorded in FY2023.
  • Quest Diagnostics' 5-year EPS (Basic) high stood at $15.85 for FY2021, and its period low was $7.59 during FY2023.
  • Its 3-year average for EPS (Basic) is $7.82, with a median of $7.78 in 2024.
  • As far as peak fluctuations go, Quest Diagnostics' EPS (Basic) skyrocketed by 66.98% in 2020, and later slumped by 48.90% in 2022.
  • Yearly analysis of 5 years shows Quest Diagnostics' EPS (Basic) stood at $10.62 in 2020, then skyrocketed by 49.25% to $15.85 in 2021, then slumped by 48.90% to $8.10 in 2022, then dropped by 6.30% to $7.59 in 2023, then increased by 2.50% to $7.78 in 2024.